Citations

Showing 10 of 107969 citations.

Reconstruction of Swan Neck Deformities after Proximal Interphalangeal Joint Arthroplasty
Froelich, John M., Rizzo, Marco

Mayo Clinic

HAND | December 9, 2013 | Volume: 9 | Issue: 1 | Pages: 93-98

10.1007/s11552-013-9571-0 | PMID 24570644 Get It

Background The authors report the use of a single slip of the flexor digitorum superficialis (FDS) as a hemitenodesis through the A2 pulley in treating swan neck deformities after previous unconstrained proximal interphalangeal joint (PIP) arthroplasty. Methods A retrospective chart review was undertaken to identify non-constrained PIP joint arthroplasties that underwent a subsequent soft tissue hemitenodesis for swan neck deformities. The range of motion (ROM), implant design, preoperative diagnosis, and surgical approach were collected. The Michigan Hand Outcomes Questionnaire and patient satisfaction questionnaire were collected. Results There were 12 patients with 14 procedures reviewed. There were seven surface replacement arthroplasties (SRA) (cobalt chrome on polyethylene) and eight pyrocarbon prostheses. The primary diagnosis for the initial joint arthroplasty was osteoarthritis (8), post-traumatic (2), and rheumatoid arthritis (5). The primary dorsal approach was a longitudinal split in eleven cases, Chamay in two, and unknown in one case. Nine of the 14 revision procedures had a concomitant dorsal approach to the joint. The average final position intra-operatively was 24.2° of flexion (range 15°–40°). Final ROM was 39° with average follow-up of 30 months. The average postoperative radiographic position was 20.3° flexion with an average of 24.8° hyperextension preoperatively. There was one failure secondary to implant loosening requiring fusion. Discussion For patients with a swan neck deformity after PIP arthroplasty, a FDS hemitenodesis provides a treatment option with a low revision rate, retained motion, and maintenance of the original implant with no shortening of the digit.
Control of Outflow Resistance by Soluble Adenylyl Cyclase
Lee, Yong Suk , Marmorstein, Alan D. , Marmorstein, Alan D

Mayo Clinic

Journal of Ocular Pharmacology and Therapeutics | December 9, 2013 | Volume: 30 | Issue: 2-3 | Pages: 138-142

10.1089/jop.2013.0199 | PMID 24320087 Get It

Abstract Glaucoma is a leading cause of blindness in the United States affecting as many as 2.2 million Americans. All current glaucoma treatment strategies aim to reduce intraocular pressure, even in patients with normal tension glaucoma. Typically, this is accomplished by reducing the rate of aqueous flow by limiting aqueous production or enhancing drainage using drugs and surgery. Whereas these strategies are effective in diminishing vision loss, some patients continue to lose vision and many discontinue use of their medications because of undesirable side effects. Drugs known to be effective in altering conventional outflow have for the most part been abandoned from modern clinical practice due to undesirable side effects. Identification of new drugs that could enhance conventional outflow, would offer additional options in the treatment of glaucoma and ocular hypertension. To this end, our laboratory has recently uncovered a novel pathway for regulation of conventional outflow by the ciliary body. This pathway is dependent on soluble adenylyl cyclase, an enzyme that catalyzes the generation of cyclic adenosine 3′,5′ monophosphate (cAMP) in response to bicarbonate.
Transesophageal Echocardiographic Imaging of Ultrasound Lung Rockets
Rehfeldt, Kent H., Bruggink, Sean M., Pulido, Juan N.

Mayo Clinic

Anesthesiology | December 9, 2013 | Volume: 121 | Issue: 6 | Pages: 1335-1335

10.1097/aln.0000000000000098 | PMID 25409196 Get It

Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma
Kaag, Matthew, Trost, Landon , Thompson, R. Houston, Favaretto, Ricardo L., Elliott, Vanessa, Maschino, Alexandra C., Vertosick, Emily , Dalbagni, Guido , Shariat, Shahrokh F. , Raman, Jay D. , Vertosick, Emily A

Mayo Clinic

BJU International | December 9, 2013 | Volume: 114 | Issue: 5 | Pages: 674-679

10.1111/bju.12597 | PMID 24314050 Get It

Objectives To model renal function after radical nephroureterectomy ( RNU ) for upper tract urothelial carcinoma ( UTUC ). To identify predictors of renal function decline after surgery, thereby allowing the identification of patients likely to be ineligible for cisplatin‐based chemotherapy in the adjuvant setting. Patients and Methods We retrospectively identified 374 patients treated with RNU for UTUC at three centres between 1995 and 2010. Estimated glomerular filtration rate ( eGFR ) was calculated using Chronic Kidney Disease Epidemiology Collaboration equation before RNU and at early (1–5 months after RNU ) and late (>5 months) time points after RNU . Only patients deemed eligible for cisplatin‐based chemotherapy before RNU (preoperative glomerular filtration rate [ GFR ] ≥60 mL/min/1.73 m 2 ) were included. Multivariable analysis identified the preoperative predictors of eGFR after RNU at early postoperative and late postoperative time points. Results A total of 163 patients had an eligible early post‐ RNU eGFR measurement and 172 had an eligible late eGFR measurement. The median eGFR declined by 32% and did not show a significant trend toward recovery over time ( P = 0.4). On multivariable analysis preoperative eGFR and patient age were significantly associated with early and late postoperative eGFR , while C harlson comorbidity index score was significantly associated with late postoperative eGFR alone. Conclusions In patients with normal preoperative eGFR (≥60 mL/min/1.73 m 2 ), renal function decreases by one‐third after RNU and does not show evidence of recovery over time. Elderly patients and those with pre‐ RNU eGFR closer to 60 mL/min/1.73 m 2 (lower eGFR in the present cohort) are more likely to be ineligible for adjuvant cisplatin‐based chemotherapy regimens because of renal function loss after RNU .
Evaluating health‐related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume
Wijnands, Titus F. M., Neijenhuis, Myrte K., Kievit, Wietske , Nevens, Frederik , Hogan, Marie C. , Drenth, Joost P.H. , Torres, Vicente E. , Gevers, Tom J.G. , Hogan, Marie C , Drenth, Joost P H

Mayo Clinic

Liver International | December 9, 2013 | Volume: 34 | Issue: 10 | Pages: 1578-1583

10.1111/liv.12430 | PMID 24313956 Get It

AbstractBackground & AimsPolycystic liver disease (PLD) follows a progressive course ultimately leading to severe hepatomegaly and mechanical complaints in a subset of patients. It is still unknown to what extent this compromises health‐related quality of life (HRQL). Our aim was to determine HRQL in PLD patients and investigate its association with concurrent abdominal symptoms and liver volume.MethodsPooled data of 92 severe PLD patients from two randomized clinical trials were used for our cross‐sectional analysis. HRQL was assessed using the generic short‐form health survey (SF‐36) resulting in eight scale scores and the summarizing physical (PCS) and mental component score (MCS). Subsequently, these were compared with the general population. Abdominal symptoms were measured with a standardized, 7‐point scale questionnaire in 54 patients. We dichotomized symptoms for absence or presence and compared them with the component scores. Finally, a possible correlation between liver volume and HRQL was explored.ResultsDemographics showed severe polycystic livers (mean 4906 ± 2315 ml). PCS was significantly lower compared with the general population (P < 0.001), in contrast with a similar MCS (P = 0.82). PLD patients had statistically significant (P < 0.05) diminished physical functioning, role physical, general health, vitality and social functioning scores. Upper‐ and lower abdominal pain and dyspnoea were significantly associated with a reduced PCS (P < 0.01). No correlation was found between liver volume and HRQL.ConclusionPolycystic liver disease patients had significantly lower HRQL in the physical dimension compared with the general population. Abdominal pain and dyspnoea had a significant impact on this physical dimension of HRQL.
Arthroscopic Femoral Neck Osteoplasty in the Treatment of Femoroacetabular Impingement
Chow, Roxanne M., Kuzma, Scott A., Krych, Aaron J. , Levy, Bruce A. , Krych, Aaron J

Mayo Clinic

Arthroscopy Techniques | December 7, 2013 | Volume: 3 | Issue: 1 | Pages: No page available

10.1016/j.eats.2013.08.007 | PMID 24749017 Get It

Abstract Femoral neck osteoplasty is an integral component for successful treatment of femoroacetabular impingement. Current techniques allow this to be performed arthroscopically, and results are equivalent to those of open procedures when typical anterior and anterosuperior lesions are considered. The arthroscopic procedure is dependent on obtaining adequate visualization through capsular management and proper leg positioning, and it requires fluoroscopy to guide and verify an adequate resection. We present our preferred technique for arthroscopic femoral neck osteoplasty. Technique Video video See video under supplementary data.
Arthroscopic Capsular Repair in the Treatment of Femoroacetabular Impingement
Chow, Roxanne M., Engasser, William M. , Krych, Aaron J. , Levy, Bruce A. , Krych, Aaron J

Mayo Clinic

Arthroscopy Techniques | December 7, 2013 | Volume: 3 | Issue: 1 | Pages: No page available

10.1016/j.eats.2013.08.006 | PMID 24749018 Get It

Abstract The role of capsular repair in the arthroscopic treatment of femoroacetabular impingement remains poorly defined. Some surgeons rarely repair the capsule, whereas others perform repairs routinely. There is little direct clinical evidence to guide surgeon decision making. When capsular repairs are performed, the procedure requires adequate visualization and careful suture placement either to re‐establish the patient's normal capsular volume or to plicate a redundant capsule in a hip with hyperlaxity preoperatively. We present our preferred technique for arthroscopic capsular repair. Technique Video video See video under supplementary data.
Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
Schiavon, Michele , Man, Chiara Dalla , Kudva, Yogish C. , Basu, Ananda , Cobelli, Claudio , Dalla Man, Chiara , Schiavon, Michele

Mayo Clinic

Diabetes Care | December 7, 2013 | Volume: 37 | Issue: 5 | Pages: 1216-1223

10.2337/dc13-1120 | PMID 24319120 Get It

OBJECTIVE The goal was to develop a new index of insulin sensitivity in patients with type 1 diabetes estimated from continuous glucose monitoring (CGM) and subcutaneous insulin delivery data under carefully controlled conditions. RESEARCH DESIGN AND METHODS The database consists of 12 subjects with type 1 diabetes, studied during breakfast, lunch, and dinner, in a clinical research unit, wearing both subcutaneous insulin pump and CGM device. Frequent blood samples were drawn for measurements of plasma glucose and insulin concentrations in order to estimate insulin sensitivity with the oral minimal model (SIMM). The new index of insulin sensitivity (SISP) was calculated with a simple algebraic formula for each meal, using only CGM and insulin pump data and compared with SIMM. RESULTS SI SP was well correlated with SIMM (r = 0.825; P &lt; 10−8), and diurnal pattern was also similar to SIMM. CONCLUSIONS A novel method for estimating insulin sensitivity in subjects with type 1 diabetes on sensor-augmented insulin pump therapy has been presented. This new index correlates well with the reference oral minimal model estimate of insulin sensitivity. The knowledge of patient-specific insulin sensitivity and its diurnal variation can help in optimizing insulin therapy in type 1 diabetes and could also inform next-generation closed-loop control systems.
Refractory status epilepticus
Fountain, Nathan B. , Fugate, Jennifer E. , Fountain, Nathan

Mayo Clinic

Neurology | December 7, 2013 | Volume: 82 | Issue: 8 | Pages: 650-651

10.1212/wnl.0000000000000008 | PMID 24319043 Get It

Cessation of contraction induces cardiomyocyte remodeling during zebrafish cardiogenesis
Yang, Jingchun , Hartjes, Katherine A., Nelson, Timothy J., Nelson, Timothy J. , Xu, Xiaolei

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | December 7, 2013 | Volume: 306 | Issue: 3 | Pages: H382-H395

10.1152/ajpheart.00721.2013 | PMID 24322613 Get It

Contraction regulates heart development via a complex mechanotransduction process controlled by various mechanical forces. Here, we exploit zebrafish embryos as an in vivo animal model to discern the contribution from different mechanical forces and identify the underlying mechanotransductive signaling pathways of cardiogenesis. We treated 2 days postfertilization zebrafish embryos with Blebbistatin, a myosin II inhibitor, to stop cardiac contraction, which induces a response termed cessation of contraction-induced cardiomyocyte (CM) enlargement (CCE). Accompanying the CCE, lateral fusion of myofibrils was attenuated within CMs. The CCE can be blunted by loss of blood in tail-docked zebrafish but not in cloche mutant fish, suggesting that transmural pressure rather than shear stress is accountable for the chamber enlargement. By screening a panel of small molecule inhibitors, our data suggested essential functions of phosphoinositide 3-kinase signaling and protein synthesis in CCE, which are independent of the sarcomere integrity. In summary, we defined a unique CCE response in genetically tractable zebrafish embryos. A panel of assays was established to verify the contribution from extrinsic forces and interrogate underlying signaling pathways.